Associated Papers
Voltage-gated potassium channels and genetic epilepsy.
Zheng Y et al.
Frontiers in Neurology, 2024
Kv1.1 Channelopathies: Pathophysiological Mechanisms and Therapeutic Approaches.
D'Adamo MC et al.
International Journal of Molecular Sciences, 2020
Epilepsy Gene Therapy Using an Engineered Potassium Channel.
Snowball A et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience, 2019
Characterizing of functional human coding RNA editing from evolutionary, structural, and dynamic perspectives.
Solomon O et al.
Proteins, 2014
Mammalian conserved ADAR targets comprise only a small fragment of the human editosome.
Pinto Y et al.
Genome Biology, 2014
K(+) channelepsy: progress in the neurobiology of potassium channels and epilepsy.
D'Adamo MC et al.
Frontiers in Cellular Neuroscience, 2013
Polyunsaturated Fatty acids modify the gating of kv channels.
Moreno C et al.
Frontiers in Pharmacology, 2012
A-to-I RNA editing modulates the pharmacology of neuronal ion channels and receptors.
Streit AK et al.
Biochemistry. Biokhimiia, 2011
RNA editing modulates the binding of drugs and highly unsaturated fatty acids to the open pore of Kv potassium channels.
Decher N et al.
The Embo Journal, 2010
Control of human potassium channel inactivation by editing of a small mRNA hairpin.
Bhalla T et al.
Nature Structural & Molecular Biology, 2004
Select a paper to view details